Integra Lifesciences Holdings Corp
NASDAQ:IART

Watchlist Manager
Integra Lifesciences Holdings Corp Logo
Integra Lifesciences Holdings Corp
NASDAQ:IART
Watchlist
Price: 10.97 USD -1.44%
Market Cap: $854.5m

Operating Margin

10.2%
Current
Declining
by 4.5%
vs 3-y average of 14.7%

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
10.2%
=
Operating Income
$167.8m
/
Revenue
$1.6B

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
10.2%
=
Operating Income
$167.8m
/
Revenue
$1.6B

Peer Comparison

Country Company Market Cap Operating
Margin
US
Integra Lifesciences Holdings Corp
NASDAQ:IART
866.3m USD
Loading...
US
Intuitive Surgical Inc
NASDAQ:ISRG
188.3B USD
Loading...
US
Abbott Laboratories
NYSE:ABT
187.1B USD
Loading...
US
Boston Scientific Corp
NYSE:BSX
138.8B USD
Loading...
US
Stryker Corp
NYSE:SYK
135B USD
Loading...
IE
Medtronic PLC
NYSE:MDT
128.9B USD
Loading...
US
Becton Dickinson and Co
NYSE:BDX
59.2B USD
Loading...
DE
Siemens Healthineers AG
XETRA:SHL
47.5B EUR
Loading...
US
IDEXX Laboratories Inc
NASDAQ:IDXX
55.6B USD
Loading...
US
Edwards Lifesciences Corp
NYSE:EW
48.5B USD
Loading...
US
Resmed Inc
NYSE:RMD
37.6B USD
Loading...

Market Distribution

In line with most companies in the United States of America
Percentile
61th
Based on 14 112 companies
61th percentile
10.2%
Low
-4 087 900% — -5.1%
Typical Range
-5.1% — 14.8%
High
14.8% — 1 032 600%
Distribution Statistics
the United States of America
Min -4 087 900%
30th Percentile -5.1%
Median 6%
70th Percentile 14.8%
Max 1 032 600%

Integra Lifesciences Holdings Corp
Glance View

Market Cap
854.5m USD
Industry
Health Care

Integra LifeSciences Holdings Corp., an influential player in the medical technology landscape, traces its origins back to a vision of creating life-enhancing innovations for surgical procedures. Founded in the late 1980s, Integra has evolved into a formidable presence, driven by a commitment to delivering solutions that improve patient outcomes in regenerative medicine and surgical care. The company operates primarily through two segments: the Codman Specialty Surgical and the Tissue Technologies segment. By focusing on these two areas, Integra leverages its expertise in surgical tools, neurocritical care, and advanced wound care, appealing to healthcare professionals worldwide. This strategic segmentation enables the company to cater to a diverse clientele, encompassing hospitals and other medical institutions in North America, Europe, and internationally. Integra's revenue streams are notably derived from the design, manufacture, and distribution of a comprehensive suite of products used in neurosurgery, acute wound care, and reconstructive surgery. The company's innovative products, including precision surgical instruments and biologics that promote regenerative tissue healing, are key contributors to its financial success. By continuously investing in research and development, Integra ensures the introduction of cutting-edge solutions that address the evolving needs of the healthcare industry. The company's growth strategy hinges on both organic innovation and strategic acquisitions, fostering an environment where technological advancements seamlessly integrate with expanding market reach. This symbiotic approach not only solidifies Integra's position in the med-tech arena but also underpins its growth potential in an ever-competitive healthcare sector.

IART Intrinsic Value
HIDDEN
Show
What is Operating Margin?
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
How is Operating Margin calculated?

Operating Margin is calculated by dividing the Operating Income by the Revenue.

Operating Margin
10.2%
=
Operating Income
$167.8m
/
Revenue
$1.6B
What is Integra Lifesciences Holdings Corp's current Operating Margin?

The current Operating Margin for Integra Lifesciences Holdings Corp is 10.2%, which is below its 3-year median of 14.7%.

How has Operating Margin changed over time?

Over the last 3 years, Integra Lifesciences Holdings Corp’s Operating Margin has decreased from 18.4% to 10.2%. During this period, it reached a low of 9.5% on Jun 30, 2025 and a high of 18.8% on Dec 31, 2022.

Back to Top